73 related articles for article (PubMed ID: 29736435)
1. Blinding properties of methods for supplying drug kits to investigational sites.
Yu R; Coleman DA
Contemp Clin Trials Commun; 2015 Oct; 1():22-27. PubMed ID: 29736435
[TBL] [Abstract][Full Text] [Related]
2. The other randomization - methods for labeling drug kits.
Coleman DA; Yu R
Contemp Clin Trials; 2014 Jul; 38(2):270-4. PubMed ID: 24854414
[TBL] [Abstract][Full Text] [Related]
3. Blinding Is Seeing: A Single-Centre Study Into the Viability of Auto-Injectors for Blinded-Drug Administration in Randomised Controlled Trials.
Aggarwal V; Taubel J; Lorch U; York T
Cureus; 2023 Aug; 15(8):e44244. PubMed ID: 37772251
[TBL] [Abstract][Full Text] [Related]
4. How to maintain the maximal level of blinding in randomisation for a placebo-controlled drug trial.
Clifton L; Clifton DA
Contemp Clin Trials Commun; 2019 Jun; 14():100356. PubMed ID: 31011659
[TBL] [Abstract][Full Text] [Related]
5. Ethics, consent and blinding: lessons from a placebo/sham controlled CPAP crossover trial.
Djavadkhani Y; Marshall NS; D'Rozario AL; Crawford MR; Yee BJ; Grunstein RR; Phillips CL
Thorax; 2015 Mar; 70(3):265-9. PubMed ID: 25595508
[TBL] [Abstract][Full Text] [Related]
6. Pre-trial evaluation of the potential for unblinding in drug trials: a prototype example.
Walter SD; Awasthi S; Jeyaseelan L
Contemp Clin Trials; 2005 Aug; 26(4):459-68. PubMed ID: 16054578
[TBL] [Abstract][Full Text] [Related]
7. Blinding strategies in the conduct and reporting of a randomized placebo-controlled device trial.
Houweling AH; Shapiro S; Cohen JM; Kahn SR
Clin Trials; 2014 Oct; 11(5):547-52. PubMed ID: 24902921
[TBL] [Abstract][Full Text] [Related]
8. Unreported formal assessment of unblinding occurred in 4 of 10 randomized clinical trials, unreported loss of blinding in 1 of 10 trials.
Bello S; Moustgaard H; Hróbjartsson A
J Clin Epidemiol; 2017 Jan; 81():42-50. PubMed ID: 27555081
[TBL] [Abstract][Full Text] [Related]
9. Changes in beliefs identify unblinding in randomized controlled trials: a method to meet CONSORT guidelines.
Rees JR; Wade TJ; Levy DA; Colford JM; Hilton JF
Contemp Clin Trials; 2005 Feb; 26(1):25-37. PubMed ID: 15837450
[TBL] [Abstract][Full Text] [Related]
10. The risk of unblinding was infrequently and incompletely reported in 300 randomized clinical trial publications.
Bello S; Moustgaard H; Hróbjartsson A
J Clin Epidemiol; 2014 Oct; 67(10):1059-69. PubMed ID: 24973822
[TBL] [Abstract][Full Text] [Related]
11. Blinding in pharmaceutical clinical trials: An overview of points to consider.
Crisp A
Contemp Clin Trials; 2015 Jul; 43():155-63. PubMed ID: 26044462
[TBL] [Abstract][Full Text] [Related]
12. Effect of Unblinding on Participants' Perceptions of Risk and Confidence in a Large Double-Blind Clinical Trial of Chemotherapy for Breast Cancer.
Partridge AH; Sepucha K; O'Neill A; Miller KD; Motley C; Swaby RF; Schneider BP; Dang CT; Northfelt DW; Sledge GW
JAMA Oncol; 2015 Jun; 1(3):369-74. PubMed ID: 26114161
[TBL] [Abstract][Full Text] [Related]
13. Unblinding and demand characteristics in the treatment of depression.
Goodwin GM; Croal M; Marwood L; Malievskaia E
J Affect Disord; 2023 May; 328():1-5. PubMed ID: 36781142
[TBL] [Abstract][Full Text] [Related]
14. Reporting of outcomes in orthopaedic randomized trials: does blinding of outcome assessors matter?
Poolman RW; Struijs PA; Krips R; Sierevelt IN; Marti RK; Farrokhyar F; Bhandari M
J Bone Joint Surg Am; 2007 Mar; 89(3):550-8. PubMed ID: 17332104
[TBL] [Abstract][Full Text] [Related]
15. Considerations for unblinding individual study participants during vaccine trials.
Halsey N; Evans S; Santosham M; Hacker A; Edwards KM; Chandler RE; Dudley MZ; Dekker CL; ; Al-Abri S; Arora N; Buttery J; Dodoo A; Eskola J; Heininger U; Jee Y; Khuri N; Obaro S; Orenstein W; Pitisuttithum P; Safadi M; Whitney CG; Black S
Vaccine; 2023 May; 41(22):3399-3402. PubMed ID: 37121805
[TBL] [Abstract][Full Text] [Related]
16. Maintaining the blind in sham controlled interventional trials: lessons from the EPISOD study.
Cotton P; Pauls Q; Wood A; Durkalski-Mauldin V
Endosc Int Open; 2019 Nov; 7(11):E1322-E1326. PubMed ID: 31673601
[No Abstract] [Full Text] [Related]
17. Assessment of blinding in clinical trials.
Bang H; Ni L; Davis CE
Control Clin Trials; 2004 Apr; 25(2):143-56. PubMed ID: 15020033
[TBL] [Abstract][Full Text] [Related]
18. First evidence of Beauvais' hypothesis in a plant model.
Thieves K; Gleiss A; Kratky KW; Frass M
Homeopathy; 2016 Aug; 105(3):270-279. PubMed ID: 27473549
[TBL] [Abstract][Full Text] [Related]
19. Blind outcome assessment: the development and use of procedures to maintain and describe blinding in a pragmatic physiotherapy rehabilitation trial.
Minns Lowe CJ; Wilson MS; Sackley CM; Barker KL
Clin Rehabil; 2011 Mar; 25(3):264-74. PubMed ID: 20971749
[TBL] [Abstract][Full Text] [Related]
20. Placebo and Side Effects Confound Clinical Trials on New Antitussives.
Eccles R
Lung; 2021 Aug; 199(4):319-326. PubMed ID: 34279718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
